Drug Shortage Report for TOBREX

Last updated on 2021-02-24 History
Report ID 123888
Drug Identification Number 00614254
Brand name TOBREX
Common or Proper name TOBREX OINTMENT 3.5 G
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) TOBRAMYCIN
Strength(s) 0.3%
Dosage form(s) OINTMENT
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 3.5 G
ATC code S01AA
ATC description ANTIINFECTIVES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-09-14
Actual start date 2020-09-10
Estimated end date 2021-03-15
Actual end date 2021-02-23
Shortage status Resolved
Updated date 2021-02-24
Company comments
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2021-02-24 English Compare
v15 2021-02-23 French Compare
v14 2021-02-23 English Compare
v13 2020-12-21 French Compare
v12 2020-12-21 English Compare
v11 2020-12-03 French Compare
v10 2020-12-03 English Compare
v9 2020-11-03 French Compare
v8 2020-11-03 English Compare
v7 2020-09-29 French Compare
v6 2020-09-29 English Compare
v5 2020-09-11 English Compare
v4 2020-09-10 French Compare
v3 2020-09-10 English Compare
v2 2020-09-08 French Compare
v1 2020-09-08 English Compare